Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial - Wikidata - wikimedia - TriplyDB

Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial

Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial

http://www.wikidata.org/entity/Q28302653

about

Effect of folic acid supplementation on cardiovascular outcomes: a systematic review and meta-analysis Interventions for lowering plasma homocysteine levels in kidney transplant recipients Interventions for lowering plasma homocysteine levels in dialysis patients Interventions for lowering plasma homocysteine levels in kidney transplant recipients The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular Study Interventions for lowering plasma homocysteine levels in dialysis patients Therapeutic modification of arterial stiffness: An update and comprehensive review Tetramethylpyrazine ameliorates high glucose-induced endothelial dysfunction by increasing mitochondrial biogenesis.Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials.N-acetylcysteine for the prevention of non-contrast media agent-induced kidney injury: from preclinical data to clinical evidence.The effect of long-term homocysteine-lowering on carotid intima-media thickness and flow-mediated vasodilation in stroke patients: a randomized controlled trial and meta-analysis.Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials Advanced chronic kidney disease, cardiovascular events and the effect of diabetes: data from the Atherosclerosis and Folic Acid Supplementation Trial.Thrombus formation induced by laser in a mouse model Folic acid supplementation and cardiac and stroke mortality among hemodialysis patients.Efficacy of homocysteine-lowering therapy with folic Acid in stroke prevention: a meta-analysis.The association between B vitamins supplementation and adverse cardiovascular events: a meta-analysis Association between B vitamins supplementation and risk of cardiovascular outcomes: a cumulative meta-analysis of randomized controlled trials.Association between adherence to folic acid supplements and serum folate, and plasma homocysteine among hemodialysis patients.Daily low-dose folic acid supplementation does not prevent nitroglycerin-induced nitric oxide synthase dysfunction and tolerance: a human in vivo study.Folic Acid Supplementation and the Risk of Cardiovascular Diseases: A Meta-Analysis of Randomized Controlled Trials Nutritional supplements for older adults: review and recommendations--Part II.Folic acid therapy and cardiovascular disease in ESRD or advanced chronic kidney disease: a meta-analysis.Relationship of MTHFR gene polymorphisms with renal and cardiac disease Effect of B-vitamin supplementation on stroke: a meta-analysis of randomized controlled trials.Role of homocysteinylation of ACE in endothelial dysfunction of arteries Association of low potassium diet and folic acid deficiency in patients with CKD Efficacy of Supplementation with B Vitamins for Stroke Prevention: A Network Meta-Analysis of Randomized Controlled Trials Emerging cardiovascular risk factors that account for a significant portion of attributable mortality risk in chronic kidney disease.Managing cardiovascular risk in people with chronic kidney disease: a review of the evidence from randomized controlled trials.Coping with new challenges in acute coronary syndromes.Native low density lipoprotein promotes lipid raft formation in macrophages.Carotid Intima-media Thickness Measurements: Relations with Atherosclerosis, Risk of Cardiovascular Disease and Application in Randomized Controlled Trials Arterial stiffness and cardiovascular outcome.Arterial calcification and stiffness in chronic kidney disease.Homocysteine lowering and cardiovascular disease risk: lost in translation Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial.Homocysteine-lowering vitamin B treatment decreases cardiovascular events in hemodialysis patients.

P2860

Q21135014-CED023DC-A098-49EA-8B7D-ED1A6873048B Q24188051-158775CF-D0C8-41CB-94C7-9341E7A1F066 Q24240554-98A0F58C-ABA2-48C7-A906-BDB68A4CF995 Q24240632-4680C1A8-8387-418F-88D9-6E5F7A73C937 Q24604736-5219D27E-D768-4C11-984E-73FBA39548FA Q24632223-104CE11E-E21F-4DAC-A96F-8401585AEB0B Q24647967-5354DEC6-10CB-40D5-9575-98E7395C3F2A Q26471859-A477CC3A-0AB5-4E55-A43E-C87C6B1EEFA8 Q26774555-F6D6530E-9181-4B49-9B36-E0098ACC5FFB Q28539558-71321F66-FFEF-4C1B-8B67-CE39FD678889 Q30430617-05491C1B-55F4-4745-8130-199BD76B8BAB Q30603357-85F29699-0FBC-44D9-ABB2-F3868CB3D754 Q33370693-416E91E7-9BF5-4F13-9E2D-6B249247294D Q33413288-36DA17BF-9AF6-4ABA-AE63-B8D91E19CDFA Q33542797-E0D73C9F-DCF9-49E6-BB58-5F741FBC561F Q33769530-6418D598-3322-4404-ADC9-3CBE4097B9E3 Q33941518-E3964DC0-D970-4119-8164-DF8D3E081C60 Q34018699-F04CA7AD-11FD-48FE-B7B8-9B871F19594E Q34166984-0D166BD4-E987-4701-ABBE-A35491BF5763 Q34215572-089B2A58-C015-4101-AD6D-B9EC11D958A9 Q34234631-74E2BEAD-61F0-410A-9382-81A3FB9B07C6 Q34338622-C17D6104-967D-4D58-9352-C9CE5474163B Q34537420-1411DF90-381C-406C-BC39-5CF1E2B3E610 Q34618719-B7FFA014-B089-49A3-9529-BD1A8685F951 Q34857539-F82AF06C-B485-484E-BF1A-711EBFC99D39 Q35050801-921431E0-93AC-41AC-9CF4-C6DE66404D5A Q35055362-564D0713-D96E-4EC6-912A-75D3006FA626 Q35120490-8A2CF43D-C5AF-49DD-A96C-B16AEDCC8C78 Q35653612-F20149C7-2531-4385-9982-6B4EAEFD4C24 Q35768939-461F3556-681B-4EC4-9C66-7BDBE5E85B42 Q35968147-68FD0840-0ADB-4D27-B900-B3975D8ADEB0 Q36443751-244C0021-E5AE-42D1-AD60-4A316C86CF9D Q36575461-B52FC82E-0C81-4630-A9DC-D6E0B384D6AA Q36624064-BFC73350-575A-422C-9F20-4B68E283821F Q36705497-C93D6B97-29A8-4362-84E0-1D1736500A21 Q36854136-F08D5062-F76C-4325-949A-7ABFD7200520 Q36854161-987D579E-CFD3-4204-B1C1-E48F646A0B0E Q36876023-36D2C7AC-D215-4F02-AF91-4BAFEB6B43C7 Q36953576-C913EBBE-384C-4645-8307-0EB76FD77B9B Q36971844-4FA98612-B4AA-4499-888C-0B878D5AF7B6

P2860

Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial

http://www.wikidata.org/entity/Q28302653

description

2006 nî lūn-bûn

@nan

2006 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի մարտին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Cardiovascular morbidity and m ...... , randomized, controlled trial

@ast

Cardiovascular morbidity and m ...... , randomized, controlled trial

@en

Cardiovascular morbidity and m ...... , randomized, controlled trial

@nl

type

label

Cardiovascular morbidity and m ...... , randomized, controlled trial

@ast

Cardiovascular morbidity and m ...... , randomized, controlled trial

@en

Cardiovascular morbidity and m ...... , randomized, controlled trial

@nl

prefLabel

Cardiovascular morbidity and m ...... , randomized, controlled trial

@ast

Cardiovascular morbidity and m ...... , randomized, controlled trial

@en

Cardiovascular morbidity and m ...... , randomized, controlled trial

@nl

P1433

Q28302653-7427FDE3-1292-41B9-890A-C55775D91470

P1476

Q28302653-F31D9128-5C79-4429-B277-20F0BF800E53

P2093

Q28302653-006BDBF2-9737-49F7-9FFD-B609B4014A52

Q28302653-260C10E8-D45D-4AC9-9E0C-588BF8FB4C93

Q28302653-3B3B6FE2-D0CF-43F6-BF68-4654B6D5A509

Q28302653-7B3FE99A-E95F-46D3-9523-89D2066B1FA0

Q28302653-927AB3CA-C216-4D64-A8DC-5E58D9777449

Q28302653-9607AE27-AE3A-46AF-9B34-AE0CDC65A132

Q28302653-CD93F675-9BF0-4494-8360-A4C74C96D376

Q28302653-E6FCD649-85F9-4095-B5CC-65674557DAEA

P304

Q28302653-E92F9F79-7145-47A1-BEEC-F39A079EDAB5

P31

Q28302653-2BF7B680-86E1-4707-9E08-C3BF48A2E925

P3181

Q28302653-A2854B2B-BB89-441E-BB98-2617ECDAE0F5

P356

Q28302653-BD7FFFBB-61AE-41A1-96F8-D6272004F5F5

P407

Q28302653-6EC6C9E1-2196-4CD7-AB3E-3832B2321F4F

P433

Q28302653-12B5F6FE-1F2F-4164-805F-FFB6E43E4B46

P478

Q28302653-A90DED2F-6020-429A-9DF1-331F6FD0FC08

P50

Q28302653-0C26C721-2A72-48BE-A7F6-BE8ADE47ADFF

Q28302653-0F78B45B-1DDB-4784-B5C3-A95F5A5B2E91

Q28302653-8D6F77C7-CD89-4884-80FC-4BB6B32E91E5

Q28302653-D51B636D-1CB7-41E2-8DEF-C940E7FC9D1B

P577

Q28302653-3EA01368-7D80-414B-8276-F13FAF969B8C

P5875

Q28302653-09D06455-AFE2-4F6A-92C7-194598CE1F0B

P698

Q28302653-3F83C23D-BEEC-408C-B519-53B4E3550CC2

P921

Q28302653-448891D0-0172-402E-AF2B-F09BD4EEE7FF

Q28302653-5D5C3FA0-4631-494A-8AEE-28EE741FA2D0

Q28302653-C04F8DC2-9B3F-4C09-ABDE-8EAB56865F2C

P3181

P356

J.JACC.2005.10.064

P1433

Journal of the American College of Cardiology

P1476

Cardiovascular morbidity and m ...... , randomized, controlled trial

@en

P2093

Barry P McGrath

http://www.w3.org/2001/XMLSchema#string

Brian G Hutchison

http://www.w3.org/2001/XMLSchema#string

Christine Muske

http://www.w3.org/2001/XMLSchema#string

Margaret Fraenkel

http://www.w3.org/2001/XMLSchema#string

Pauline Branley

http://www.w3.org/2001/XMLSchema#string

Peter G Kerr

http://www.w3.org/2001/XMLSchema#string

Robert C Atkins

http://www.w3.org/2001/XMLSchema#string

Robert Walker

http://www.w3.org/2001/XMLSchema#string

P304

1108-16

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4080443

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.JACC.2005.10.064

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7232539

http://www.w3.org/2001/XMLSchema#string

P698

16545638

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio

atherosclerosis

multicenter trial